Coordinatore | UNIVERSITY OF GLASGOW
Organization address
address: University Avenue contact info |
Nazionalità Coordinatore | United Kingdom [UK] |
Totale costo | 188˙800 € |
EC contributo | 147˙000 € |
Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
Code Call | FP7-PEOPLE-2010-IRSES |
Funding Scheme | MC-IRSES |
Anno di inizio | 2012 |
Periodo (anno-mese-giorno) | 2012-01-01 - 2014-12-31 |
# | ||||
---|---|---|---|---|
1 |
UNIVERSITY OF GLASGOW
Organization address
address: University Avenue contact info |
UK (GLASGOW) | coordinator | 12˙600.00 |
2 |
ISTITUTO SUPERIORE DI SANITA
Organization address
address: Viale Regina Elena 299 contact info |
IT (ROMA) | participant | 37˙800.00 |
3 |
KAROLINSKA INSTITUTET
Organization address
address: Nobels Vag 5 contact info |
SE (STOCKHOLM) | participant | 18˙900.00 |
4 |
UNIVERSITAETSKLINIKUM HEIDELBERG
Organization address
address: IM NEUENHEIMER FELD 672 contact info |
DE (HEIDELBERG) | participant | 18˙900.00 |
5 |
PHILIPPS UNIVERSITAET MARBURG
Organization address
address: Biegenstrasse 10 contact info |
DE (MARBURG) | participant | 14˙700.00 |
6 | KOBENHAVNS UNIVERSITET | DK | participant | 12˙600.00 |
7 |
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE
Organization address
address: KEPPEL STREET contact info |
UK (LONDON) | participant | 12˙600.00 |
8 |
UNIVERSITE DE GENEVE
Organization address
address: Rue du General Dufour 24 contact info |
CH (GENEVE) | participant | 12˙600.00 |
9 |
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD contact info |
UK (LONDON) | participant | 6˙300.00 |
10 |
BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN
Organization address
address: BERNHARD NOCHT STRASSE 74 contact info |
DE (HAMBURG) | participant | 0.00 |
11 |
INSTITUT PASTEUR
Organization address
address: RUE DU DOCTEUR ROUX 25-28 contact info |
FR (PARIS CEDEX 15) | participant | 0.00 |
12 |
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.
Organization address
address: Hofgartenstrasse 8 contact info |
DE (MUENCHEN) | participant | 0.00 |
13 |
MEDICAL RESEARCH COUNCIL
Organization address
address: NORTH STAR AVENUE POLARIS HOUSE contact info |
UK (SWINDON) | participant | 0.00 |
14 |
STICHTING KATHOLIEKE UNIVERSITEIT
Organization address
address: GEERT GROOTEPLEIN NOORD 9 contact info |
NL (NIJMEGEN) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'54 partners from 34 institutes have formed an EC-funded Network of Excellence (NoE) in basic malaria research, the European Virtual Institute for Malaria Research (EVIMalaR). Over the previous >5 years as the NoE Biomalpar these partners successfully broke down many barriers to cooperation pursuing a programme of integrated research. This was greatly assisted by the Biomalpar PhD School whose students were supervised by two partners from different member states. Evimalar represents the latest incarnation of this network and has recruited in tranches 21 students into the Evimalar PhD School. Australian malaria researchers have also realised the greater benefits of collaborative research and within the Australian Parasitology Network have exchanged personnel and expertise. Both the European and Australian networks recognised that their domestic spirit of cooperation could be mutualised and signed a Memorandum of Understanding (MoU) in 2007 (updated in 2010) to formalise the ambition. The MoU generated greater exchange between the regions but was limited due to lack of finance. Evimalar created a legal link between the regions by incorporating an Australian malaria researcher who was then applied for funding from the Australian NHMRC to finance OzEMalaR, a mechanism for exchange of Australians to Evimalar partners. Ozmalnet seeks reciprocal funding to allow Evimalar researchers to conduct exchange visits to OzEMalaR laboratories. Both regions are world leaders in malaria research with particular local strengths that can be exploited to the mutual benefit of both regions and their early stage researchers including Evimalar PhD students who will primarily be undertaking the exchanges. The outcome will be a more globalised integration of malaria research and greater exchange of information and personnel in the future leading to collaborative grants and ultimately concerted efforts to defeat malaria one of the greatest scourges of mankind.'
Malaria is a widespread mosquito-borne parasitic disease and the cause of death for millions of people. With no effective vaccination and increasing drug resistance it is imperative to integrate international malaria research to find innovative solutions.
The EU-funded project 'Towards the establishment of a framework in malaria between the AMRN and EVIMALAR' http://www.evimalar.org/irses/irses.html (OZMALNET) has organised a network of excellence, the European Virtual Institute for Malaria Research (EVIMALAR). The Australian malaria research network (AMRN) has provided funding for their researchers abroad through the 'Australia - Europe Malaria Research Cooperation' (OZEMALAR) initiative.
Together, EVIMALAR and AMRN have facilitatated malarial research cooperation incorporating networking and staff exchange between Australian and European institutes. EVIMALAR created a legal link between the two regions to enable reciprocal funding and early stage researcher (ESR) exchange via OZMALNET and OZEMALAR.
Already, several ESR exchanges have been completed between top Australian and European malarial research institutes and still more are ongoing or planned. These ESRs performed cutting edge research and learned novel techniques that will also prove useful in future research endeavours. The exchange of malarial parasites and experiment results between Europe and Australia should facilitate better research integration and knowledge exchange.
The malarial parasite enters the merozoite life cycle stage in the human hosts' liver. An ESR from a European institute has practised the novel merozoite purification method from an Australian laboratory. Imaging purified merozoites should provide better insight into the pathogenesis of this disease. Besides this, other ESR exchanges have taken place and the researchers have learnt various biochemical techniques and methods including metabolomic analysis. Characterisation of important proteins such as PfGEXPs and coronin in the malarial parasite promise novel avenues for therapy and vaccine development.
Project activities have strengthened research networks and ties between Australia and Europe. This should promote further research collaborations and enhance ESR careers. ESR exchange will also facilitate knowledge exchange and bring about a more coordinated global research effort against the deadly parasite. Integrated research initiatives in particular could lead to the development of novel anti-malarial drugs and vaccines and other control measures.